Search research articles
Contact Us
Filters
Showing results (301-310 of 329) with videos related to
Page
of 33
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 2, 2020
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT
Alicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, et al.
Plos One
|
February 24, 2009
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment
Verena Ilona Carrara, Julien Zwang, Elizabeth A Ashley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 18, 2016
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo, Elizabeth A Ashley, Tim J C Anderson, et al.
Wellcome Open Research
|
October 25, 2017
Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar
Jordi Landier, Ladda Kajeechiwa, May Myo Thwin, et al.
Open Forum Infectious Diseases
|
January 16, 2026
<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand
Cindy S Chu, Khin Maung Lwin, Kathy Burgoine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Claudia Turner, et al.
The Lancet. Microbe
|
June 22, 2024
Implementation of the WHO Tricycle protocol for surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment in Madagascar: a prospective genomic epidemiology study
Milen Milenkov, Caroline Proux, Tiavina Lalaina Rasolofoarison, et al.
BMC Medicine
|
June 10, 2021
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
Makoto Saito, Verena I Carrara, Mary Ellen Gilder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 12, 2018
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Khin Maung Lwin, et al.
Malaria Journal
|
February 24, 2019
The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar
Jade D Rae, Suphak Nosten, Stéphane Proux, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 329) with videos related to
Sort By:
Page
of 33
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 2, 2020
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT
Alicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, et al.
Plos One
|
February 24, 2009
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment
Verena Ilona Carrara, Julien Zwang, Elizabeth A Ashley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 18, 2016
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo, Elizabeth A Ashley, Tim J C Anderson, et al.
Wellcome Open Research
|
October 25, 2017
Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar
Jordi Landier, Ladda Kajeechiwa, May Myo Thwin, et al.
Open Forum Infectious Diseases
|
January 16, 2026
<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand
Cindy S Chu, Khin Maung Lwin, Kathy Burgoine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Claudia Turner, et al.
The Lancet. Microbe
|
June 22, 2024
Implementation of the WHO Tricycle protocol for surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment in Madagascar: a prospective genomic epidemiology study
Milen Milenkov, Caroline Proux, Tiavina Lalaina Rasolofoarison, et al.
BMC Medicine
|
June 10, 2021
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
Makoto Saito, Verena I Carrara, Mary Ellen Gilder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 12, 2018
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Cindy S Chu, Aung Pyae Phyo, Khin Maung Lwin, et al.
Malaria Journal
|
February 24, 2019
The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar
Jade D Rae, Suphak Nosten, Stéphane Proux, et al.
Page
of 33